Report Detail

Pharma & Healthcare Global Cancer Drug Therapy Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM4592474
  • |
  • 05 June, 2024
  • |
  • Global
  • |
  • 137 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Cancer Drug Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Kidney cancer or renal cancer is one of the ten most frequently diagnosed cancers, found mainly in people aged 60 or above. According to the estimates of the American Cancer Society (ACS), 61,560 new kidney cancer cases and 14,080 deaths would occur in 2015. Due to the increasing prevalence with no cure of this deadly disease, till date, there is an imminent need for effective kidney cancer drugs.

The renal cancer drug therapy market has witnessed a dramatic change in its treatment paradigm over the last three decades. Although, there are a variety of treatment options available, innovators have now shifted their focus towards more targeted therapies and immunotherapies. The market is primarily driven by lifestyle affecting factors such as reduced physical activity, excessive smoking and drinking. Rising aging population and the mounting prevalence of kidney cancer cases are some of the additional factors boosting the growth of the market. Strong pipeline and fast-emerging treatments are expected to further boost the market during the analysis period. However, high cost of drugs, looming off-patents and uncertain reimbursement policies are some of the factors that are likely to restrain the market growth.

Winning a physicians confidence regarding the cost, efficacy and dosage would lead to a higher acceptance of drugs in the market. Additionally, immunotherapies would emerge as an opportunity for innovators in the kidney cancer drugs market. Furthermore, untapped geographies with a high undiagnosed patient base would offer lucrative opportunities for the innovators in future. However, overcoming the generic drugs competition would be a key challenge for the leading innovators.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Cancer Drug Therapy industry chain, the market status of Angiogenesis Inhibitors (Targeted Therapy, Chemotherapy), mTOR Inhibitors (Targeted Therapy, Chemotherapy), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cancer Drug Therapy.
Regionally, the report analyzes the Cancer Drug Therapy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cancer Drug Therapy market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Cancer Drug Therapy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cancer Drug Therapy industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Targeted Therapy, Chemotherapy).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cancer Drug Therapy market.
Regional Analysis: The report involves examining the Cancer Drug Therapy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cancer Drug Therapy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Cancer Drug Therapy:
Company Analysis: Report covers individual Cancer Drug Therapy manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cancer Drug Therapy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Angiogenesis Inhibitors, mTOR Inhibitors).
Technology Analysis: Report covers specific technologies relevant to Cancer Drug Therapy. It assesses the current state, advancements, and potential future developments in Cancer Drug Therapy areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cancer Drug Therapy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Cancer Drug Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Targeted Therapy
Chemotherapy
Immunotherapy
Market segment by Application
Angiogenesis Inhibitors
mTOR Inhibitors
Monoclonal Antibodies
Cytokine Immunotherapy (IL-2)
Major players covered
Amgen / Allergan
Argos Therapeutics
AstraZeneca
Aveo Pharmaceuticals
Bayer
Exelixis
Incyte
Merck
Roche
Bristol-Myers Squibb
Eisai
Exelixis
Genentech (Roche)
Novartis
Pfizer
Prometheus Labs
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cancer Drug Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cancer Drug Therapy, with price, sales, revenue and global market share of Cancer Drug Therapy from 2019 to 2024.
Chapter 3, the Cancer Drug Therapy competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cancer Drug Therapy breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Cancer Drug Therapy market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cancer Drug Therapy.
Chapter 14 and 15, to describe Cancer Drug Therapy sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Cancer Drug Therapy
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Cancer Drug Therapy Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Targeted Therapy
    • 1.3.3 Chemotherapy
    • 1.3.4 Immunotherapy
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Cancer Drug Therapy Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Angiogenesis Inhibitors
    • 1.4.3 mTOR Inhibitors
    • 1.4.4 Monoclonal Antibodies
    • 1.4.5 Cytokine Immunotherapy (IL-2)
  • 1.5 Global Cancer Drug Therapy Market Size & Forecast
    • 1.5.1 Global Cancer Drug Therapy Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Cancer Drug Therapy Sales Quantity (2019-2030)
    • 1.5.3 Global Cancer Drug Therapy Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Amgen / Allergan
    • 2.1.1 Amgen / Allergan Details
    • 2.1.2 Amgen / Allergan Major Business
    • 2.1.3 Amgen / Allergan Cancer Drug Therapy Product and Services
    • 2.1.4 Amgen / Allergan Cancer Drug Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Amgen / Allergan Recent Developments/Updates
  • 2.2 Argos Therapeutics
    • 2.2.1 Argos Therapeutics Details
    • 2.2.2 Argos Therapeutics Major Business
    • 2.2.3 Argos Therapeutics Cancer Drug Therapy Product and Services
    • 2.2.4 Argos Therapeutics Cancer Drug Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Argos Therapeutics Recent Developments/Updates
  • 2.3 AstraZeneca
    • 2.3.1 AstraZeneca Details
    • 2.3.2 AstraZeneca Major Business
    • 2.3.3 AstraZeneca Cancer Drug Therapy Product and Services
    • 2.3.4 AstraZeneca Cancer Drug Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 AstraZeneca Recent Developments/Updates
  • 2.4 Aveo Pharmaceuticals
    • 2.4.1 Aveo Pharmaceuticals Details
    • 2.4.2 Aveo Pharmaceuticals Major Business
    • 2.4.3 Aveo Pharmaceuticals Cancer Drug Therapy Product and Services
    • 2.4.4 Aveo Pharmaceuticals Cancer Drug Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Aveo Pharmaceuticals Recent Developments/Updates
  • 2.5 Bayer
    • 2.5.1 Bayer Details
    • 2.5.2 Bayer Major Business
    • 2.5.3 Bayer Cancer Drug Therapy Product and Services
    • 2.5.4 Bayer Cancer Drug Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Bayer Recent Developments/Updates
  • 2.6 Exelixis
    • 2.6.1 Exelixis Details
    • 2.6.2 Exelixis Major Business
    • 2.6.3 Exelixis Cancer Drug Therapy Product and Services
    • 2.6.4 Exelixis Cancer Drug Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Exelixis Recent Developments/Updates
  • 2.7 Incyte
    • 2.7.1 Incyte Details
    • 2.7.2 Incyte Major Business
    • 2.7.3 Incyte Cancer Drug Therapy Product and Services
    • 2.7.4 Incyte Cancer Drug Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Incyte Recent Developments/Updates
  • 2.8 Merck
    • 2.8.1 Merck Details
    • 2.8.2 Merck Major Business
    • 2.8.3 Merck Cancer Drug Therapy Product and Services
    • 2.8.4 Merck Cancer Drug Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Merck Recent Developments/Updates
  • 2.9 Roche
    • 2.9.1 Roche Details
    • 2.9.2 Roche Major Business
    • 2.9.3 Roche Cancer Drug Therapy Product and Services
    • 2.9.4 Roche Cancer Drug Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Roche Recent Developments/Updates
  • 2.10 Bristol-Myers Squibb
    • 2.10.1 Bristol-Myers Squibb Details
    • 2.10.2 Bristol-Myers Squibb Major Business
    • 2.10.3 Bristol-Myers Squibb Cancer Drug Therapy Product and Services
    • 2.10.4 Bristol-Myers Squibb Cancer Drug Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Bristol-Myers Squibb Recent Developments/Updates
  • 2.11 Eisai
    • 2.11.1 Eisai Details
    • 2.11.2 Eisai Major Business
    • 2.11.3 Eisai Cancer Drug Therapy Product and Services
    • 2.11.4 Eisai Cancer Drug Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Eisai Recent Developments/Updates
  • 2.12 Exelixis
    • 2.12.1 Exelixis Details
    • 2.12.2 Exelixis Major Business
    • 2.12.3 Exelixis Cancer Drug Therapy Product and Services
    • 2.12.4 Exelixis Cancer Drug Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Exelixis Recent Developments/Updates
  • 2.13 Genentech (Roche)
    • 2.13.1 Genentech (Roche) Details
    • 2.13.2 Genentech (Roche) Major Business
    • 2.13.3 Genentech (Roche) Cancer Drug Therapy Product and Services
    • 2.13.4 Genentech (Roche) Cancer Drug Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Genentech (Roche) Recent Developments/Updates
  • 2.14 Novartis
    • 2.14.1 Novartis Details
    • 2.14.2 Novartis Major Business
    • 2.14.3 Novartis Cancer Drug Therapy Product and Services
    • 2.14.4 Novartis Cancer Drug Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Novartis Recent Developments/Updates
  • 2.15 Pfizer
    • 2.15.1 Pfizer Details
    • 2.15.2 Pfizer Major Business
    • 2.15.3 Pfizer Cancer Drug Therapy Product and Services
    • 2.15.4 Pfizer Cancer Drug Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 Pfizer Recent Developments/Updates
  • 2.16 Prometheus Labs
    • 2.16.1 Prometheus Labs Details
    • 2.16.2 Prometheus Labs Major Business
    • 2.16.3 Prometheus Labs Cancer Drug Therapy Product and Services
    • 2.16.4 Prometheus Labs Cancer Drug Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 Prometheus Labs Recent Developments/Updates

3 Competitive Environment: Cancer Drug Therapy by Manufacturer

  • 3.1 Global Cancer Drug Therapy Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Cancer Drug Therapy Revenue by Manufacturer (2019-2024)
  • 3.3 Global Cancer Drug Therapy Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Cancer Drug Therapy by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Cancer Drug Therapy Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Cancer Drug Therapy Manufacturer Market Share in 2023
  • 3.5 Cancer Drug Therapy Market: Overall Company Footprint Analysis
    • 3.5.1 Cancer Drug Therapy Market: Region Footprint
    • 3.5.2 Cancer Drug Therapy Market: Company Product Type Footprint
    • 3.5.3 Cancer Drug Therapy Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Cancer Drug Therapy Market Size by Region
    • 4.1.1 Global Cancer Drug Therapy Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Cancer Drug Therapy Consumption Value by Region (2019-2030)
    • 4.1.3 Global Cancer Drug Therapy Average Price by Region (2019-2030)
  • 4.2 North America Cancer Drug Therapy Consumption Value (2019-2030)
  • 4.3 Europe Cancer Drug Therapy Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Cancer Drug Therapy Consumption Value (2019-2030)
  • 4.5 South America Cancer Drug Therapy Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Cancer Drug Therapy Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Cancer Drug Therapy Sales Quantity by Type (2019-2030)
  • 5.2 Global Cancer Drug Therapy Consumption Value by Type (2019-2030)
  • 5.3 Global Cancer Drug Therapy Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Cancer Drug Therapy Sales Quantity by Application (2019-2030)
  • 6.2 Global Cancer Drug Therapy Consumption Value by Application (2019-2030)
  • 6.3 Global Cancer Drug Therapy Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Cancer Drug Therapy Sales Quantity by Type (2019-2030)
  • 7.2 North America Cancer Drug Therapy Sales Quantity by Application (2019-2030)
  • 7.3 North America Cancer Drug Therapy Market Size by Country
    • 7.3.1 North America Cancer Drug Therapy Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Cancer Drug Therapy Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Cancer Drug Therapy Sales Quantity by Type (2019-2030)
  • 8.2 Europe Cancer Drug Therapy Sales Quantity by Application (2019-2030)
  • 8.3 Europe Cancer Drug Therapy Market Size by Country
    • 8.3.1 Europe Cancer Drug Therapy Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Cancer Drug Therapy Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Cancer Drug Therapy Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Cancer Drug Therapy Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Cancer Drug Therapy Market Size by Region
    • 9.3.1 Asia-Pacific Cancer Drug Therapy Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Cancer Drug Therapy Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Cancer Drug Therapy Sales Quantity by Type (2019-2030)
  • 10.2 South America Cancer Drug Therapy Sales Quantity by Application (2019-2030)
  • 10.3 South America Cancer Drug Therapy Market Size by Country
    • 10.3.1 South America Cancer Drug Therapy Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Cancer Drug Therapy Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Cancer Drug Therapy Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Cancer Drug Therapy Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Cancer Drug Therapy Market Size by Country
    • 11.3.1 Middle East & Africa Cancer Drug Therapy Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Cancer Drug Therapy Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Cancer Drug Therapy Market Drivers
  • 12.2 Cancer Drug Therapy Market Restraints
  • 12.3 Cancer Drug Therapy Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Cancer Drug Therapy and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Cancer Drug Therapy
  • 13.3 Cancer Drug Therapy Production Process
  • 13.4 Cancer Drug Therapy Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Cancer Drug Therapy Typical Distributors
  • 14.3 Cancer Drug Therapy Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Cancer Drug Therapy. Industry analysis & Market Report on Cancer Drug Therapy is a syndicated market report, published as Global Cancer Drug Therapy Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Cancer Drug Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,724.84
    4,087.26
    5,449.68
    3,236.40
    4,854.60
    6,472.80
    546,429.60
    819,644.40
    1,092,859.20
    290,823.60
    436,235.40
    581,647.20
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report